International trade · 24/01/2007

U.S. International Trade Commission Extends Investigation Timeline for MVA Vaccines and Pharmaceutical Compositions

The U.S. International Trade Commission has requested additional information and extended the deadline for its investigation into MVA vaccines and pharmaceutical compositions, which is related to Certain Modified Vaccinia Ankara (“MVA”) Viruses and Vaccines and Pharmaceutical Compositions Based Thereon.